Gastrointestinal tract
Gastric adenocarcinoma
Worldwide the second commonest cancer; often found late. A malignant ulcer cannot be told from a benign one by eye, so every gastric ulcer and mass needs a biopsy.
Causes and risk factors
- Long-standing H. pylori gastritis (though few infected people develop cancer)
- For the intestinal type: pickled or smoked foods, nitrosamines from nitrites, and excess salt
Gross pathology
- A shallow ulcer or an exophytic mass, often in the antrum.
- The diffuse type can infiltrate the whole wall (linitis plastica).
Under the microscope
- Intestinal type: irregular neoplastic glands infiltrating the wall, with mitoses, hyperchromatic nuclei and a desmoplastic stroma.
How it develops
- Chronic gastritis, for example from H. pylori, persists for years.
- Genetic changes (TP53 mutation, abnormal E-cadherin) accumulate.
- Early cancer stays in the mucosa and is silent; it can be found by endoscopic screening.
- Advanced cancer invades the wall and metastasises.
Complications
- Nausea, vomiting, abdominal pain, haematemesis, weight loss and dysphagia
- Late diagnosis with invasion or metastasis
Investigations
- Upper endoscopy with multiple biopsies
- Shows an ulcerated or diffusely infiltrating tumour; histology confirms intestinal or diffuse (signet ring) type.
- CT and endoscopic ultrasound
- CT stages spread; endoscopic ultrasound shows depth of invasion and local nodes.
- Helicobacter pylori tests
- Chronic infection is the main cause of the intestinal type.
- Full blood count
- Iron-deficiency anaemia from bleeding.
Drug treatment
- Fluoropyrimidines (5-fluorouracil, capecitabine): Antimetabolites that starve dividing cells of thymidine for DNA; the backbone of chemotherapy for colorectal cancer, including cancer that has spread to the liver.
- Platinum compounds (cisplatin, carboplatin, oxaliplatin): Cytotoxic drugs that cross-link DNA; the backbone of chemotherapy for lung, testicular, gastric and colorectal cancers and osteosarcoma. Each has its own toxicity: cisplatin the kidney and ear, carboplatin the marrow, oxaliplatin the nerves.
- HER2-targeted drugs (trastuzumab): Antibodies and kinase inhibitors aimed at the HER2 receptor, overexpressed in about a fifth of breast cancers; trastuzumab greatly improves survival in HER2-positive disease, with a risk of reversible heart dysfunction.
Anatomy involved
Connected topics
Written from
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 7, The Gastrointestinal Tract, pp. 191–192, figs 7-47 to 7-50
Educational reference. Not medical advice, diagnosis or treatment.